rs199702315

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2

The NM_003664.5(AP3B1):​c.2409_2411delGAA​(p.Lys804del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 1,523,058 control chromosomes in the GnomAD database, including 294 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 28 hom., cov: 32)
Exomes 𝑓: 0.018 ( 266 hom. )

Consequence

AP3B1
NM_003664.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.78

Publications

7 publications found
Variant links:
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]
AP3B1 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_003664.5. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 5-78101011-TTTC-T is Benign according to our data. Variant chr5-78101011-TTTC-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 179635.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0142 (2162/152258) while in subpopulation NFE AF = 0.02 (1358/67960). AF 95% confidence interval is 0.0191. There are 28 homozygotes in GnomAd4. There are 1056 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP3B1NM_003664.5 linkc.2409_2411delGAA p.Lys804del disruptive_inframe_deletion Exon 21 of 27 ENST00000255194.11 NP_003655.3
AP3B1NM_001271769.2 linkc.2262_2264delGAA p.Lys755del disruptive_inframe_deletion Exon 21 of 27 NP_001258698.1
AP3B1NM_001410752.1 linkc.2409_2411delGAA p.Lys804del disruptive_inframe_deletion Exon 21 of 23 NP_001397681.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP3B1ENST00000255194.11 linkc.2409_2411delGAA p.Lys804del disruptive_inframe_deletion Exon 21 of 27 1 NM_003664.5 ENSP00000255194.7

Frequencies

GnomAD3 genomes
AF:
0.0142
AC:
2165
AN:
152140
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00396
Gnomad AMI
AF:
0.0658
Gnomad AMR
AF:
0.0112
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0330
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0200
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0136
AC:
3069
AN:
226264
AF XY:
0.0133
show subpopulations
Gnomad AFR exome
AF:
0.00338
Gnomad AMR exome
AF:
0.00649
Gnomad ASJ exome
AF:
0.00507
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0354
Gnomad NFE exome
AF:
0.0192
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.0175
AC:
24053
AN:
1370800
Hom.:
266
AF XY:
0.0172
AC XY:
11757
AN XY:
684740
show subpopulations
African (AFR)
AF:
0.00286
AC:
90
AN:
31506
American (AMR)
AF:
0.00605
AC:
260
AN:
42994
Ashkenazi Jewish (ASJ)
AF:
0.00489
AC:
123
AN:
25168
East Asian (EAS)
AF:
0.0000257
AC:
1
AN:
38878
South Asian (SAS)
AF:
0.00134
AC:
109
AN:
81568
European-Finnish (FIN)
AF:
0.0362
AC:
1891
AN:
52284
Middle Eastern (MID)
AF:
0.00412
AC:
23
AN:
5582
European-Non Finnish (NFE)
AF:
0.0199
AC:
20641
AN:
1035558
Other (OTH)
AF:
0.0160
AC:
915
AN:
57262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.423
Heterozygous variant carriers
0
956
1913
2869
3826
4782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
728
1456
2184
2912
3640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2162
AN:
152258
Hom.:
28
Cov.:
32
AF XY:
0.0142
AC XY:
1056
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.00394
AC:
164
AN:
41582
American (AMR)
AF:
0.0111
AC:
170
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.0330
AC:
350
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0200
AC:
1358
AN:
67960
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
103
206
308
411
514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0154
Hom.:
5
Bravo
AF:
0.0123
Asia WGS
AF:
0.00145
AC:
5
AN:
3458

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 10, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lys804del in exon 21 of AP3B1: This variant is not expected to have clinical sig nificance because it has been identified in 1.85% (161/8721) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs199702315). -

Hermansky-Pudlak syndrome 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Feb 19, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.8
Mutation Taster
=78/22
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199702315; hg19: chr5-77396835; COSMIC: COSV105838833; API